Searchable abstracts of presentations at key conferences in endocrinology

ea0008p42 | Diabetes, metabolism and cardiovascular | SFE2004

ELECTRON BEAM CT MEASUREMENT OF CORONARY ARTERY CALCIUM ALLOWS INDIVIDUAL RISK ASSESSMENT OF CHD IN UK DIABETIC PATIENTS

Jenkins PJ , McArthur T , Salek C , Tighe M , Howling SJ

IntroductionCurrent guidelines advocate the use of statins in all patients with diabetes for primary prevention of CHD, regardless of cholesterol levels. Measurement of coronary artery calcium score (CACS) in diabetic patients is reported to offer a superior prognostic assessment of an individual's risk of cardiovascular disease than the Framingham Risk assessment. To date, there have been no studies of CACS in the UK diabetic population.<p class="ab...

ea0008dp21 | Diabetes, metabolism and cardiovascular | SFE2004

ELECTRON BEAM CT MEASUREMENT OF CORONARY ARTERY CALCIUM ALLOWS INDIVIDUAL RISK ASSESSMENT OF CHD IN UK DIABETIC PATIENTS

Jenkins PJ , McArthur T , Salek C , Tighe M , Howling SJ

IntroductionCurrent guidelines advocate the use of statins in all patients with diabetes for primary prevention of CHD, regardless of cholesterol levels. Measurement of coronary artery calcium score (CACS) in diabetic patients is reported to offer a superior prognostic assessment of an individual's risk of cardiovascular disease than the Framingham Risk assessment. To date, there have been no studies of CACS in the UK diabetic population.<p class="ab...

ea0011oc40 | Neuroendocrinology and neoplasia | ECE2006

Expression of IGF-I & IGF-IR in tamoxifen sensitive and tamoxifen resistant breast cancer

McVittie CJ , Khalaf S , Ogunkolade W , Carpenter R , Bustin SA , Jenkins PJ

Background: The growth hormone/ IGF-I axis is important in the pathogenesis of breast cancer and increased IGF-I signalling through the IGF-I receptor (IGF-IR) has been implicated in the development of tamoxifen resistance in breast cancer.Aims: To compare mRNA and protein expression of IGF-I & IGF-IR in (i) wild type (WT) and tamoxifen resistant (TR) MCF-7 breast cancer cells and (ii) breast cancer tissue from women with primary and recurrent, tamox...

ea0011p477 | Endocrine tumours and neoplasia | ECE2006

Insulin-like growth factor-i signalling in tamoxifen sensitive and tamoxifen resistant breast cancer cells

McVittie CJ , Khalaf S , Ogunkolade W , Carpenter R , Bustin SA , Jenkins PJ

Background: Due to its cross-talk with estrogen receptor (ER) signalling, increased IGF-I signalling through the IGF-I receptor (IGF-IR) has been postulated as an important factor in the development of tamoxifen resistance in breast cancer.Aims: To investigate the importance of IGF-I signalling in tamoxifen resistant (TR) and wild-type (WT) MCF-7 breast cancer cells by (i) assessing cell proliferation in response to IGF-I and tamoxifen and (ii) using sma...

ea0011p765 | Steroids | ECE2006

NaB affect the local regulation of vitamin D in colorectal cancer

Ogunkolade BW , Khalaf S , Boucher BJ , Davis D , Dorudi S , Jenkins PJ , Bustin SA

Introduction: The development of colorectal cancer is influenced by dietary as well as growth factors. Butyrate, (NaB) one of the metabolic by-products of bacterial fermentation of dietary fibre is a primary source of energy for colonic mucosa. It has growth-promoting effects on normal colonic epithelial cells, induces cell cycle arrest, differentiation and apoptosis in colorectal cancer cells. Since it has been suggested that the apoptotic effects of NaB may be due to its syn...

ea0011p855 | Thyroid | ECE2006

Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patients

Agha A , Walker D , Drake WM , Chew SL , Grossman AB , Jenkins PJ , Monson JP

The effect of growth hormone (GH) replacement on thyroid function in hypopituitary patients has only been studied in small groups of children and adults with conflicting results.We aimed to define the effect and clinical significance of adult GH replacement on thyroid status in a large cohort of 243 patients with hypopituitarism due to various causes. 84 patients were considered euthyroid before GH treatment and 159 patients had central hypothyroidism an...

ea0019p266 | Pituitary | SFEBES2009

Fifteen years experience of repeated colonoscopic screening of patients with acromegaly shows a high incidence of new colonic neoplasia and allows for effective screening guidelines

Dworakowska D , Gueorguiev M , Kelly P , Grossman AB , Monson JP , Besser GM , Chew SL , Akker S , Drake WM , Fairclough PD , Jenkins PJ

Introduction: Patients with acromegaly have an increased risk of colorectal cancer and pre-malignant adenomatous polyps; however the frequency of colonoscopic screening remains unclear.Aims: To determine optimum frequency for repeated colonoscopy of acromegalic patients.Methods: Since 1992, 254 patients (mean age 56.6 years) at our centre have undergone at least one fibre-optic colonoscopic surveillance; 156, 60 and 15 patients hav...

ea0011p179 | Clinical practise and governance | ECE2006

Improvements for patients and nurses using 2.5 ml prefilled syringes as the vehicle solution for suspension of Sandostatin LAR® microspheres

Maher KT , Drake WM , Besser GM , Grossman AB , Chew SL , Jenkins PJ , Kalingag LA , Fode FK , O’Sullivan-Hawketts MT , Walker DM , Monson JP

The preparation of Sandostatin LAR® injections using a 2 ml ampoule of vehicle solution may be associated with some technical difficulties of administration, with adverse consequences for patients. The development of a 2.5 ml prefilled syringe may alleviate some of these problems. We have compared these two methods of Sandostatin LAR® administration in 17 patients with acromegaly and 5 patients with neuro-endocrine tumours, (6 drug naïve, 1...